|
Market Cap (16-May) $82,472,520 (825th) |
Close (30-Jun) $1.50 |
Volume (30-Jun) 19,997 |
Shortsold (12-Dec) 1,378 (0.00%) (711th) |
|
52w High $1.33 |
52w Low $1.10 |
P/E - |
EPS - |
CD3 released this announcement to the ASX on 29 November 2022, 16:13. The announcement is marked as price sensitive, and is 25 page(s) in length and 0.98MB in size.
You can view all announcements from CD3 and see how they appear on a price chart on the announcements page.
At the date of this announcement, CD3 was 0.002% short sold according to ASIC data. It was ranked the 711th most shorted stock on the ASX. It remains ranked 711th as of the latest reported data (12 December 2022).
| Other Recent Announcements from CD3 | |
|---|---|
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:27 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:25 |
| Appendix 3Z - Final Director's Interest Notice | 30 June 2023, 10:22 |
| Half-yearly report and accounts - 30 September 2022 | 29 November 2022, 16:13 |
| Fund Payment Notice | 24 November 2022, 15:33 |
| Quarterly investment update - September 2022 | 15 November 2022, 15:03 |
| Net Tangible Asset Backing & Fund Update | 14 November 2022, 16:28 |
You must be logged in to post a reply.
